[Predictors for locoregional recurrence after radical prostatectomy].

Petrovskij, N V; Krupinov, G E; Amosov, A V; Chinenov, D V; N, Gerasimenko A; Glybochko, P V

Petrovskij, N V; Krupinov, G E; Amosov, A V; Chinenov, D V; N, Gerasimenko A; Glybochko, P V.

Afiliação

Petrovskij NV; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Krupinov GE; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Amosov AV; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Chinenov DV; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
N GA; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Glybochko PV; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.

Urologiia ; (2): 100-105, 2021 May.

Article em Ru | MEDLINE | ID: mdl-33960167

Assuntos

Antígeno Prostático Específico; Neoplasias da Próstata; Humanos; Masculino; Recidiva Local de Neoplasia/patologia; Estadiamento de Neoplasias; Próstata/patologia; Prostatectomia; Neoplasias da Próstata/patologia; Neoplasias da Próstata/cirurgia

Palavras-chave

Gleason's sum; prostate cancer; prostatic specific antigen; recurrence of prostate cancer

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: Ru Ano de publicação: 2021 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links